FDA Breakthrough Therapy designation and initiates two phase III trials in MASH for survodutide » Globe Newswire - TCN.VN

Subsea7 - Seaway7 awarded offshore wind contract 14-02-2023, 14:07

Mavenir and OXIO Powering the Next Generation of MVNOs 27-02-2025, 00:53

Zib Digital Explores the Possible Role AI Will Play in the 27-02-2023, 09:11

8-10-2024, 13:35

Boehringer receives U.S. FDA Breakthrough Therapy designation and initiates two phase III trials in MASH for survodutide

Globe Newswire8-10-2024, 13:35

Liên hệ quảng cáo

Hotline hỗ trợ quảng cáo: 0914.222.131
Email: quangcao@vietsoftgroup.com

Email: info@vietsoftgroup.com

© Copyright 2019 - Trang tin tức chuyên đề giới trẻ TCN News - Toàn bộ bài viết được chi sẻ bởi các thành viên.